Aspetuck Financial Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Buy
11,450
+650
+6% +$76.1K 0.87% 30
2026
Q1
$1.3M Sell
10,800
-14
-0.1% -$1.62K 0.89% 31
2025
Q4
$1.14M Buy
10,814
+65
+0.6% +$6.1K 0.76% 33
2025
Q3
$902K Buy
10,749
+3,100
+41% +$255K 0.62% 33
2025
Q2
$605K Sell
7,649
-37
-0.5% -$2.94K 0.46% 43
2025
Q1
$690K Sell
7,686
-6,124
-44% -$572K 0.59% 34
2024
Q4
$1.37M Buy
+13,810
New +$1.42M 1.07% 29

Other funds holding MRK

Aspetuck Financial Management's MRK Position: Q2 2026 in Review

Aspetuck Financial Management increased its Merck (MRK) stake by 6% in Q2 2026, buying an estimated $76.1K and bringing the position to 11,450 shares worth $1.47M. The position accounts for 0.87% of the portfolio, ranked #30.

Aspetuck Financial Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aspetuck Financial Management held 11,450 shares of Merck worth $1.47M as of Q2 2026.
  • Aspetuck Financial Management bought 650 Merck shares in Q2 2026, an estimated $76.1K.
  • Merck made up 0.87% of Aspetuck Financial Management's portfolio in Q2 2026, its #30 holding.
  • Aspetuck Financial Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aspetuck Financial Management's 13F filing for Q2 2026, filed 11 Aug 2026.